(124)I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo

Because of the recent development of an iodopyridopyrimidinone Abl protein kinase inhibitor (PKI), (124)I-SKI-212230 ((124)I-SKI230), we investigated the feasibility of a PET-based molecular imaging method for the direct visualization of Abl kinase expression and PKI treatment. METHODS: In vitro pha...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Nucl Med
Asıl Yazarlar: Doubrovin, Mikhail, Kochetkova, Tatiana, Santos, Elmer, Veach, Darren R., Smith-Jones, Peter, Pillarsetty, Nagavarakishore, Balatoni, Julius, Bornmann, William, Gelovani, Juri, Larson, Steven M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4432838/
https://ncbi.nlm.nih.gov/pubmed/20048131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.109.066126
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller